Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2010
10/14/2010WO2010117951A1 Inhibitors of soluble epoxide hydrolase to inhibit or prevent niacin-induced flushing
10/14/2010WO2010117873A2 Progesterone solutions for increased bioavailability
10/14/2010WO2010117668A1 Polymer-agent conjugates, particles, compositions, and related methods of use
10/14/2010WO2010117419A2 Method of determining body exit of an ingested capsule
10/14/2010WO2010117296A1 Agent for preventing influenza and acute respiratory diseases
10/14/2010WO2010117266A1 In situ gelling alginate systems
10/14/2010WO2010117091A2 Antimycotic pharmaceutical composition
10/14/2010WO2010117089A2 Antimycotic pharmaceutical composition
10/14/2010WO2010117050A1 Solid preparation containing dibenz[b,e]oxepine derivative
10/14/2010WO2010117035A1 Complex and process for production thereof, and granules and tablets
10/14/2010WO2010116382A2 Stable pharmaceutical compositions of diclofenac
10/14/2010WO2010116336A1 Uses of red yeast rice in treating dengue virus infection
10/14/2010WO2010116312A1 Modular ingestible drug delivery capsule
10/14/2010WO2010116281A2 Substrates having a cleaning composition for improved glide over skin
10/14/2010WO2010116267A1 High dosage doramectin formulation
10/14/2010WO2010116185A1 Insulin stabilized nanoparticles
10/14/2010WO2010116098A1 Compositions comprising at least one complex composed of a derivative of naphthoic acid and of at least one cyclodextrin and uses thereof
10/14/2010WO2010116090A1 Therapeutic applications in the cardiovascular field of quinazolinedione derivatives
10/14/2010WO2010116078A1 Foaming pharmaceutical composition that does not contain a propellant gas
10/14/2010WO2010115947A2 Prolonged-release alfa-lipoic acid
10/14/2010WO2010115937A1 Process for preparing pyrrolidinium salts
10/14/2010WO2010115886A1 Active pharmaceutical ingredient adsorbed on solid support
10/14/2010WO2010115728A2 A method for avoiding glass fogging
10/14/2010WO2010115724A1 Oral films comprising 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro- 1h-quinolin-2-one base or salts or hydrates thereof
10/14/2010WO2010115612A2 Pregabalin compositions
10/14/2010WO2010115576A1 Melting tablet containing a sildenafil salt
10/14/2010WO2010115475A1 Process for producing rapidly disintegrating spheroids (pellets), granules and/or mixtures thereof
10/14/2010WO2010115442A1 Chewing mass for obtaining nucleic acids for determining sequence variants
10/14/2010WO2010115426A1 Skin care compositions for the delivery of agents
10/14/2010WO2010115342A1 SUSTAINED RELEASE COMPOSITION CONTAINING TETRAHYDROPYRIDO [4, 3-b] INDOLE DERIVATIVE AND PREPARATION METHOD OF DERIVATIVE
10/14/2010WO2010115267A1 Once-daily oral ir/cr pramipexole formulation
10/14/2010WO2010089772A3 Chronotherapeutic pharmaceutical composition
10/14/2010WO2010080580A3 Extended-release pharmaceutical formulations
10/14/2010WO2010075072A3 Long circulating nanoparticles for sustained release of therapeutic agents
10/14/2010WO2010070664A4 Curcuminoids and its metabolites for the application in ocular diseases
10/14/2010WO2010068705A3 Encapsulated agent guided imaging and therapies
10/14/2010WO2010065061A3 Modular ingestible capsule
10/14/2010WO2010062570A3 COMPOSITIONS COMPRISING CAPTURE PEPTIDES FOR A β-AMYLOID PEPTIDE
10/14/2010WO2010059253A9 Methods and compositions for localized agent delivery
10/14/2010WO2010059244A3 Method for reducing thrombocytopenia and thrombocytopenia-associated mortality
10/14/2010WO2010020799A3 Compositions for the treatment of neoplastic diseases
10/14/2010WO2010020518A3 Improvements relating to nanodisperse compositions
10/14/2010WO2009151498A3 Memantine formulations
10/14/2010WO2009120182A3 Sulfo-polymer powder and sulfo-polymer powder blends with carriers and/or actives
10/14/2010WO2009110005A3 Modified release pharmaceutical compositions comprising mycophenolate and processes thereof
10/14/2010WO2009101518A3 Gellan gum based hydrogels for regenerative medicine and tissue engineering applications, its system, and processing devices
10/14/2010WO2009075582A4 Acoustically sensitive drug delivery particles comprising non-lamellar forming lipids
10/14/2010WO2009053885A3 Methods for preparing polymer microparticles
10/14/2010US20100262224 Stent Made From An Ultra High Molecular Weight Bioabsorbable Polymer With High Fatigue And Fracture Resistance
10/14/2010US20100262115 Nanoparticles for cancer sonodynamic and photodynamic therapy
10/14/2010US20100261756 method for inhibiting platelet aggregation
10/14/2010US20100261748 Stable loratadine spill resistant formulation
10/14/2010US20100261746 Pharmaceutical formulation
10/14/2010US20100261745 Pharmaceutical formulation
10/14/2010US20100261744 Pharmaceutical formulation
10/14/2010US20100261713 Pharmaceutical formulation containing irritant
10/14/2010US20100261672 Pharmaceutical compositions of pyrimidine-2,4,6-triones
10/14/2010US20100261662 Utilization of mural thrombus for local drug delivery into vascular tissue
10/14/2010US20100261273 Mammalian Receptor Proteins; Related Reagents and Methods
10/14/2010US20100260860 Methods for Treating Vasomotor Symptoms in Castrated Prostatic Cancer Patients with Low Dose Cyproterone Acetate
10/14/2010US20100260859 Controlled-release clozapine compositions
10/14/2010US20100260858 Drug delivery composition
10/14/2010US20100260857 Enzyme delivery systems and methods of preparation and use
10/14/2010US20100260856 Core particle for pharmaceutical preparation
10/14/2010US20100260855 Delivery of as-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
10/14/2010US20100260854 Granulate for the formulation of orodispersible tablets
10/14/2010US20100260853 Compositions for pulmonary delivery
10/14/2010US20100260852 Laxative agent
10/14/2010US20100260851 Novel Polymorph of Atorvastatin Calcium and Use Thereof for the Preparation of Amorphous Atorvastatin Calcium
10/14/2010US20100260850 Controlled Release Devices and Methods for Delivery of Nucleic Acids
10/14/2010US20100260848 System for controlled release of an active principle and method for preparation
10/14/2010US20100260847 Tissue matrices comprising placental stem cells
10/14/2010US20100260846 Particles for delivery of nucleic acids and related devices and methods
10/14/2010US20100260844 Oral pharmaceutical dosage forms
10/14/2010US20100260843 Regeneration and repair of neural tissue using postpartum-derived cells
10/14/2010US20100260842 Pseudoephedrine pharmaceutical formulations
10/14/2010US20100260841 Method of Treating Atherosclerosis, Dyslipidemias and Related Conditions
10/14/2010US20100260840 Orodispersible pharmaceutical composition of agomelatine
10/14/2010US20100260839 Aqueous film coating solution, film coated granule and tablet using the same
10/14/2010US20100260838 Method and composition for administering an nmda receptor antagonist to a subject
10/14/2010US20100260837 Bioavailable Capsule Compositions of Amorphous Alpha-(N-Sulfonamido)Acetamide Compound
10/14/2010US20100260836 Kits and methods for nutrition supplementation
10/14/2010US20100260835 Pharmaceutical composition
10/14/2010US20100260834 Abuse-deterrent drug formulations
10/14/2010US20100260833 Abuse-proofed dosage form
10/14/2010US20100260832 Combination therapy for ovarian cancer
10/14/2010US20100260831 Non-pegylated liposomal doxorubicin triple combination therapy
10/14/2010US20100260830 Liposomal Formulations of Tocopheryl Amides
10/14/2010US20100260829 Sustained Release of Antiinfectives
10/14/2010US20100260828 Modulation of Platelet Aggregation
10/14/2010US20100260827 Methods of diagnosing, preventing and treating cancer metastasis
10/14/2010US20100260826 Patch and patch preparation
10/14/2010US20100260825 Antifolates for the treatment of cardiovascular, inflammatory, neoplastic, autoimmune and related diseases in sublingual dosage units, film strips, or skin patches
10/14/2010US20100260821 Allergen Desensitization Method
10/14/2010US20100260819 Reducing post-operative adhesion formation with intraperitoneal glutamine
10/14/2010US20100260818 Stable medicated chewing gum comprising cyclodextrin inclusion complex
10/14/2010US20100260816 Induction of immunological tolerance
10/14/2010US20100260815 Fluid concentrator, autologous concentrated body fluids, and uses thereof
10/14/2010US20100260812 Thickened fluid composition comprising chlorine dioxide
10/14/2010US20100260811 Novel compositions of fat-soluble substances
1 ... 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 ... 2991